CoChat
Sign Up
Cited by 155

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Lung Cancer Signatures in Plasma Based on Proteome Profiling of Mouse Tumor Models

Taguchi, Ayumu, Politi, Katerina, Pitteri, Sharon J., Lockwood, William W., Faça, Vitor M., Kelly-Spratt, Karen, Wong, Chee-Hong, Zhang, Qing, Chin, Alice, Park, Kwon-Sik, Goodman, Gary, Gazdar, Adi F., Sage, Julien, Dinulescu, Daniela M., Kucherlapati, Raju, DePinho, Ronald A., Kemp, Christopher J., Varmus, Harold E., Hanash, Samir M.·2011·Cancer Cell
DOI 10.1016/j.ccr.2011.08.007PMC PMC3406925
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ccr.2011.08.007

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • GGAs regulate TGN-endosome trafficking of many cargo molecules with ACLL motifs including sortilin, mannose-6-phosphate receptors, B-secretase, stabilin-1, chloride channel 7, consortin and others.

    “In this manner, GGAs have been shown to regulate the TGN-endosome trafficking of many cargo molecules with ACLL motifs including sortilin32, manose-6-phosphate receptors33, B-secretase34, stabilin-134, chloride channel 734, consortin35 and others.”

    From Integrative Genomic Analyses Identifies GGA2 as a Cooperative Driver of EGFR-Mediated Lung Tumorigenesis (2019) · cites this paper as [33]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 51

  1. Ben-Ezra, 1994, Small cell carcinomas of the lung express the Bcl-2 protein, Am. J. Pathol., 145, 1036
  2. Bild, 2006, Oncogenic pathway signatures in human cancers as a guide to targeted therapies, Nature, 439, 353, 10.1038/nature04296 · DOI
  3. Bingle, 2006, WFDC2 (HE4): a potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lung, Respir. Res., 7, 61, 10.1186/1465-9921-7-61 · DOI
  4. Camenisch, 2002, ANGPTL3 stimulates endothelial cell adhesion and migration via integrin alpha vbeta 3 and induces blood vessel formation in vivo, J. Biol. Chem., 277, 17281, 10.1074/jbc.M109768200 · DOI
  5. De Vita, 1998, Serum concentrations of proinflammatory cytokines in advanced non small cell lung cancer patients, J. Exp. Clin. Cancer Res., 17, 413
  6. Deng, 2009, Clinicopathological features and epidermal growth factor receptor mutations associated with epithelial-mesenchymal transition in non-small cell lung cancer, Respirology, 14, 371, 10.1111/j.1440-1843.2009.01496.x · DOI
  7. Ding, 2011, SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression, Nature, 470, 269, 10.1038/nature09677 · DOI
  8. Dinulescu, 2005, Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer, Nat. Med., 11, 63, 10.1038/nm1173 · DOI
  9. Eisen, 1998, Cluster analysis and display of genome-wide expression patterns, Proc. Natl. Acad. Sci. USA, 95, 14863, 10.1073/pnas.95.25.14863 · DOI · Paper page
  10. Faca, 2006, Quantitative analysis of acrylamide labeled serum proteins by LC-MS/MS, J. Proteome Res., 5, 2009, 10.1021/pr060102+ · DOI
  11. Faça, 2009, In-depth proteomics to define the cell surface and secretome of ovarian cancer cells and processes of protein shedding, Cancer Res., 69, 728, 10.1158/0008-5472.CAN-08-3087 · DOI
  12. Faca, 2008, A mouse to human search for plasma proteome changes associated with pancreatic tumor development, PLoS Med., 5, e123, 10.1371/journal.pmed.0050123 · DOI
  13. Galgano, 2006, Comprehensive analysis of HE4 expression in normal and malignant human tissues, Mod. Pathol., 19, 847, 10.1038/modpathol.3800612 · DOI
  14. Goodman, 2004, The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements, J. Natl. Cancer Inst., 96, 1743, 10.1093/jnci/djh320 · DOI
  15. Hellström, 2003, The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma, Cancer Res., 63, 3695
  16. Horio, 1996, Ki-ras and p53 mutations are early and late events, respectively, in urethane-induced pulmonary carcinogenesis in A/J mice, Mol. Carcinog., 17, 217, 10.1002/(SICI)1098-2744(199612)17:4<217::AID-MC5>3.0.CO;2-A · DOI
  17. Hung, 2009, Comprehensive proteome analysis of an Apc mouse model uncovers proteins associated with intestinal tumorigenesis, Cancer Prev Res (Phila), 2, 224, 10.1158/1940-6207.CAPR-08-0153 · DOI
  18. Huot, 2009, Identification of a Sam68 ribonucleoprotein complex regulated by epidermal growth factor, J. Biol. Chem., 284, 31903, 10.1074/jbc.M109.018465 · DOI
  19. Kaminska, 2006, Pretreatment serum levels of cytokines and cytokine receptors in patients with non-small cell lung cancer, and correlations with clinicopathological features and prognosis: M-CSF—an independent prognostic factor, Oncology, 70, 115, 10.1159/000093002 · DOI
  20. Kelly-Spratt, 2011, Plasma proteome profiles associated with inflammation, angiogenesis, and cancer, PLoS ONE, 6, e19721, 10.1371/journal.pone.0019721 · DOI
  21. Koishi, 2002, Angptl3 regulates lipid metabolism in mice, Nat. Genet., 30, 151, 10.1038/ng814 · DOI · Paper page
  22. Lara, 2006, Bortezomib (PS-341) in relapsed or refractory extensive stage small cell lung cancer: a Southwest Oncology Group phase II trial (S0327), J. Thorac. Oncol., 1, 996, 10.1097/01243894-200611000-00013 · DOI
  23. Ledermann, 1994, Detection of the neural cell adhesion molecule (NCAM) in serum of patients with small-cell lung cancer (SCLC) with “limited” or “extensive” disease, and bone-marrow infiltration, Int. J. Cancer Suppl., 8, 49, 10.1002/ijc.2910570710 · DOI
  24. Lemos-González, 2007, Alteration of the serum levels of the epidermal growth factor receptor and its ligands in patients with non-small cell lung cancer and head and neck carcinoma, Br. J. Cancer, 96, 1569, 10.1038/sj.bjc.6603770 · DOI
  25. Lin, 2009, Deep depletion of abundant serum proteins reveals low-abundant proteins as potential biomarkers for human ovarian cancer, Proteomics Clin. Appl., 3, 853, 10.1002/prca.200800141 · DOI
  26. Maretzky, 2005, ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and beta-catenin translocation, Proc. Natl. Acad. Sci. USA, 102, 9182, 10.1073/pnas.0500918102 · DOI
  27. McCulloch, 2004, Expression of the disintegrin metalloprotease, ADAM-10, in prostate cancer and its regulation by dihydrotestosterone, insulin-like growth factor I, and epidermal growth factor in the prostate cancer cell model LNCaP, Clin. Cancer Res., 10, 314, 10.1158/1078-0432.CCR-0846-3 · DOI
  28. Meylan, 2009, Requirement for NF-kappaB signalling in a mouse model of lung adenocarcinoma, Nature, 462, 104, 10.1038/nature08462 · DOI
  29. Moody, 2002, Conditional activation of Neu in the mammary epithelium of transgenic mice results in reversible pulmonary metastasis, Cancer Cell, 2, 451, 10.1016/S1535-6108(02)00212-X · DOI
  30. Murai, 2004, Engagement of CD44 promotes Rac activation and CD44 cleavage during tumor cell migration, J. Biol. Chem., 279, 4541, 10.1074/jbc.M307356200 · DOI
  31. Pérez-Gil, 2008, Structure of pulmonary surfactant membranes and films: the role of proteins and lipid-protein interactions, Biochim. Biophys. Acta, 1778, 1676, 10.1016/j.bbamem.2008.05.003 · DOI
  32. Pernemalm, 2009, Use of narrow-range peptide IEF to improve detection of lung adenocarcinoma markers in plasma and pleural effusion, Proteomics, 9, 3414, 10.1002/pmic.200800814 · DOI
  33. Pitteri, 2008, Plasma proteome profiling of a mouse model of breast cancer identifies a set of up-regulated proteins in common with human breast cancer cells, J. Proteome Res., 7, 1481, 10.1021/pr7007994 · DOI
  34. Pitteri, 2009, Integrated proteomic analysis of human cancer cells and plasma from tumor bearing mice for ovarian cancer biomarker discovery, PLoS ONE, 4, e7916, 10.1371/journal.pone.0007916 · DOI
  35. Pitteri, 2011, Tumor microenvironment-derived proteins dominate the plasma proteome response during breast cancer induction and progression, Cancer Res., 71, 5090, 10.1158/0008-5472.CAN-11-0568 · DOI
  36. Ponta, 2003, CD44: from adhesion molecules to signalling regulators, Nat. Rev. Mol. Cell Biol., 4, 33, 10.1038/nrm1004 · DOI
  37. Qiu, 2008, Occurrence of autoantibodies to annexin I, 14-3-3 theta and LAMR1 in prediagnostic lung cancer sera, J. Clin. Oncol., 26, 5060, 10.1200/JCO.2008.16.2388 · DOI
  38. Schaffer, 2010, Loss of p130 accelerates tumor development in a mouse model for human small-cell lung carcinoma, Cancer Res., 70, 3877, 10.1158/0008-5472.CAN-09-4228 · DOI
  39. Schmid, 2010, Dual inhibition of EGFR and mTOR pathways in small cell lung cancer, Br. J. Cancer, 103, 622, 10.1038/sj.bjc.6605761 · DOI
  40. Solassol, 2010, Serum protein signature may improve detection of ductal carcinoma in situ of the breast, Oncogene, 29, 550, 10.1038/onc.2009.341 · DOI
  41. Tanaka, 2007, Lineage-specific dependency of lung adenocarcinomas on the lung development regulator TTF-1, Cancer Res., 67, 6007, 10.1158/0008-5472.CAN-06-4774 · DOI
  42. Van't Westeinde, 2011, Screening and early detection of lung cancer, Cancer J., 17, 3, 10.1097/PPO.0b013e3182099319 · DOI
  43. Vangsted, 1994, New serum markers for small-cell lung cancer. II. The neural cell adhesion molecule, NCAM, Cancer Detect. Prev., 18, 291
  44. Vanier, 2004, Structure and function of the NPC2 protein, Biochim. Biophys. Acta, 1685, 14, 10.1016/j.bbalip.2004.08.007 · DOI
  45. Wang, 2003, Induction of tumor angiogenesis by Slit-Robo signaling and inhibition of cancer growth by blocking Robo activity, Cancer Cell, 4, 19, 10.1016/S1535-6108(03)00164-8 · DOI
  46. Warzecha, 2009, ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing, Mol. Cell, 33, 591, 10.1016/j.molcel.2009.01.025 · DOI
  47. Weg-Remers, 2001, Regulation of alternative pre-mRNA splicing by the ERK MAP-kinase pathway, EMBO J., 20, 4194, 10.1093/emboj/20.15.4194 · DOI
  48. Weir, 2007, Characterizing the cancer genome in lung adenocarcinoma, Nature, 450, 893, 10.1038/nature06358 · DOI · Paper page
  49. Xian, 2001, Inadequate lung development and bronchial hyperplasia in mice with a targeted deletion in the Dutt1/Robo1 gene, Proc. Natl. Acad. Sci. USA, 98, 15062, 10.1073/pnas.251407098 · DOI
  50. Yan, 2002, The metalloprotease Kuzbanian (ADAM10) mediates the transactivation of EGF receptor by G protein-coupled receptors, J. Cell Biol., 158, 221, 10.1083/jcb.200112026 · DOI
  51. Yee, 2009, Connective tissue-activating peptide III: a novel blood biomarker for early lung cancer detection, J. Clin. Oncol., 27, 2787, 10.1200/JCO.2008.19.4233 · DOI

Cited by

Sorted by citations

Metadata

Authors
Taguchi, A., Politi, K., Pitteri, S. J., Lockwood, W. W., Faça, V. M., Kelly-Spratt, K., Wong, C.-H., Zhang, Q., Chin, A., Park, K.-S., Goodman, G., Gazdar, A. F., Sage, J., Dinulescu, D. M., Kucherlapati, R., DePinho, R. A., Kemp, C. J., Varmus, H. E., & Hanash, S. M.
Venue
Cancer Cell
Publisher
Elsevier BV
Published
2011-09
Volume
20
Issue
3
Pages
289-299
ISSN
1535-6108
DOI
10.1016/j.ccr.2011.08.007
PMC
PMC3406925
Cited by
155
References
4
Language
en
Licence
Funders
  • Burroughs Wellcome Fund
  • U.S. Department of Defense (W81XWH-10-1-0263)
  • National Cancer Institute

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review